vimarsana.com

Latest Breaking News On - Beth hougen - Page 1 : vimarsana.com

Ionis Pharmaceuticals : 1Q24 Earnings Slides

Ionis Pharmaceuticals : 1Q24 Earnings Slides
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Q4 2023 Earnings Call Transcript

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcript February 21, 2024 Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.78. Ionis Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to […]

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Q3 2023 Earnings Call Transcript

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2023 Earnings Call Transcript November 2, 2023 Ionis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-1.01. Operator: Good morning, and welcome to Ionis’ Third Quarter 2023 Financial Results Conference Call. As a reminder this call is being recorded. At this time, I would like […]

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Ionis Third Quarter 2023 Financial Results Conference Call. As a reminder this call is being recorded. At this time, I would like to turn the call over Mr.

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Q2 2023 Earnings Call Transcript

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript August 9, 2023 Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.6, expectations were $-0.94. Operator: Good morning, and welcome to Ionis’ Second Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.